I see Alix post a lot on LinkedIn about disruption, industries facing structural tailwinds, etc.
Wondering if an rx consultant can go down the path where your responsibilities are more aligned with this macro side of restructuring, as opposed to the purely individual company’s distress that you usually think of when it comes to rx.
| +223 | Who Killed Wall Street | 65 | 1d |
| +192 | Worlds Worst MDs Competition (2026 Edition) | 43 | 1h |
| +167 | As Lehman people reconvene at UBS, Barclays needs to hire (2023) | 23 | 5d |
| +123 | Lindsay Clancy - Thoughts from A2 | 22 | 2d |
| +74 | Only Indians cold emailing | 37 | 21m |
| +50 | UBS Healthcare | 25 | 35m |
| +48 | NYC Wall Street Run Club | 12 | 9h |
| +43 | EB (EVR/CVP/LAZ) vs MBB (Bain/BCG) | 21 | 1d |
| +40 | Shana tova - happy new year | 5 | 11h |
| +36 | Most technical groups? | 18 | 2d |
Career Resources
Get instant access to lessons taught by experienced private equity pros and bulge bracket investment bankers including financial statement modeling, DCF, M&A, LBO, Comps and Excel Modeling.
